About the study
Am I eligible?
This study involves receiving 3 doses of a novel malaria vaccine candidate, each administered one
month apart. One month following the final vaccine dose, participants will receive an injection with
infectious malaria parasites to examine the effectiveness of the vaccine. If there is evidence of a
developing malaria infection/at the completion of the study, anti-malarial drugs will be
administered. Reasonable travel and parking costs will be reimbursed as well as a nominal
fee for reimbursement of time ($50/visit).
- Healthy males aged 18-50 years of age who are non-smokers/smoke ≤ 5 cigarettes/day.
- Further eligibility criteria will be assessed in screening visits and involve assessment of medical
history and blood test results.
If you are interested in participating in this trial and meet the eligibility criteria, please register your details below and we will get in contact with you: